by Jasmine | May 22, 2020 | News
VANCOUVER, British Columbia, May 22, 2020 – Veritas Pharma Inc.’s (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) (“Veritas” or the “Company”) is pleased to announce that on May 14th, 2020, the company entered into a Letter of Intent (“LOI”) to acquire Indigenous...
by Jasmine | May 21, 2020 | News
VANCOUVER, British Columbia, May 21st, 2020 – Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) (“Veritas” or the “Company”) wishes to announce that as a result of a review of its continuous disclosures record by the British Columbia Securities...
by Jasmine | Apr 27, 2020 | News
VANCOUVER, British Columbia, April 27th, 2020 – Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) (“Veritas” or the “Company”) wishes to announce that it has issued 1,215,789 options to directors and officers of the Company under the stock option...
by Sam Eskandari | Apr 24, 2020 | News
VANCOUVER, British Columbia, April 24th, 2020 – Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) (“Veritas” or the “Company”) wishes to announce that it has appointed Lorne Mark Roseborough as Chairman of the Board. The Company also wishes to...
by Sam Eskandari | Feb 19, 2020 | News
VANCOUVER, British Columbia, February 19, 2019 — Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) (“Veritas” or the “Company”) wishes to announces that it has entered into a debt settlement agreement with its Interim CEO and CFO, Mr. Peter...
by Sam Eskandari | Feb 13, 2020 | News
VANCOUVER, British Columbia, February 13, 2020 – Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) (“Veritas” or the “Company”) announces its preliminary human study results of its lead cannabis treatment for acute pain, CTL-X, as well as, the...
